EIF4E and neoplasm: 4EGI-1 has shown anti-tumor activity by inhibiting proliferation and inducing apoptosis in Jurkat T-ALL and A549 cancer cell lines in vitro.240 Moreover, Ribavirin, an eIF4E inhibitor, has shown striking improvements as monotherapy in an 11-patient clinical trial for acute myeloid leukemia.241